KRYS Earnings
Latest Revenue119.2M
Latest Net Income54.8M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $1.85 | 119.2M | 54.8M | +24.1% | +39.1% |
| Q1 2026 | $1.91 | 116.4M | 55.9M | +31.9% | +54.0% |
| Q4 2025 | $1.77 | 107.1M | 51.4M | +17.5% | +12.0% |
| Q3 2025 | $2.74 | 97.8M | 79.4M | +16.6% | +188.4% |
| Q2 2025 | $1.33 | 96.0M | 38.3M | +36.6% | +146.3% |
| Q1 2025 | $1.24 | 88.2M | 35.7M | +94.9% | +4,033.3% |
| Q4 2024 | $1.58 | 91.1M | 45.5M | +116.3% | +409.7% |
| Q3 2024 | $0.95 | 83.8M | 27.2M | +879.9% | -67.0% |
| Q2 2024 | $0.54 | 70.3M | 15.6M | — | — |
| Q1 2024 | $0.03 | 45.3M | 932.0K | — | — |
| Q4 2023 | $0.31 | 42.1M | 8.7M | — | — |
| Q3 2023 | $2.88 | 8.6M | 80.7M | — | — |
Krystal Biotech (KRYS) — Earnings